MUMBAI: Breast cancer is the most common cancer globally, with an annual incidence of almost 200,000 in India. India ranks highest in the number of estimated breast cancer deaths (98,337) for the year 2022 among females. It is against this background that there is a worldwide focus on cancer diagnostics and technological advancements to help patients with early detection and safer medical and surgical interventions.
In this regard, Apollo Cancer Centre in Navi Mumbai performed Maharashtra’s first robotic nipple-sparing mastectomy with reconstruction using TiLoop—a new procedure in breast cancer prevention and reconstruction. Its doctors claimed this technique increased safety during surgery as well as aesthetic outcomes for patients.
Breast cancer surgeon Dr Sandip Bipte operated on a 43-year-old Navi Mumbai resident, Jyoti (name changed), on 3rd January, and she was discharged the next day. He said that the new technique not only preserves the skin and nipple, but also allows for a natural breast appearance. “There are no visible scars on the breast, ensuring an excellent cosmetic outcome,” he added. It also provides better sensory preservation compared to conventional mastectomy and promotes faster healing as it is a minimally invasive technique.
Jyoti spoke about her battle with breast cancer, which began with the detection of cancer in her right breast in mid-2024. During tests, she was diagnosed as a carrier of the onco-gene, the BRCA gene, indicating that she had a 70-80% lifetime risk of developing cancer in the other breast as well. She first underwent breast-conserving surgery on the right breast, but due to her positive BRCA status, she soon had to decide whether to undergo a prophylactic mastectomy on the left breast. It was only when she heard about the robotic nipple-sparing mastectomy option that she made up her mind.
Traditional breast reconstruction in India involves extensive surgery, longer operating time, additional scars on different parts of the body, and prolonged hospital stays with increased chances of complications. Senior medical oncologist Dr Suresh H Advani said, “The procedure is not just a technical achievement; it is a testament to the ever-evolving understanding of compassionate cancer care. This approach elevates the standards of treatment while prioritising the dignity and emotional resilience of patients.”
Dr Bipte added that by prioritising both physical and emotional well-being, the patient is empowered and experiences a renewed sense of confidence and self-assurance.
